BrukerFRA:BKD +8.79%85 FCF Margin % is 5.71% as of Mar. 2026, which is 12% below its 10-year median of 6.52. GuruFocus rates FRA:BKD with a GF Score™ of 85/100 and a GF Value™ of €53.30 (Fairly Valued). The stock has 10 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Bruker ranks better than 51.78% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bruker's Free Cash Flow for the
three
months ended in Mar. 2026 was €41 Mil. Bruker's Revenue for the
three
months ended in Mar. 2026 was €712 Mil. Therefore, Bruker's FCF Margin % for the quarter that ended in Mar. 2026 was 5.71%.
The historical rank and industry rank for Bruker's FCF Margin % or its related term are showing as below:
FRA:BKD'
s FCF Margin % Range Over the Past 10 Years
Min: 0.4 Med: 6.52 Max: 11.82
Current: 0.59
During the past 13 years, the highest FCF Margin % of Bruker was 11.82%. The lowest was 0.40%. And the median was 6.52%.
FRA:BKD's FCF Margin % is ranked better than 51.78% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs FRA:BKD: 0.59
Bruker FCF Margin % Related Terms
Bruker FCF Margin % Historical Data
* Premium members only.
The historical data trend for Bruker's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:BKD vs MASI, BIO, PODD: FCF Margin % Comparison
For the Medical Devices subindustry, Bruker's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bruker FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bruker's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Bruker's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bruker (FRA:BKD) has a FCF Margin % of 5.71% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bruker and its competitors. This is 12% below median its historical median of 6.52. Over the past decade, Bruker's FCF Margin % has ranged from 0.40 to 11.82. According to the industry distribution chart, Bruker ranks #393 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 48.2%.
Is Bruker's FCF Margin % too high?
Bruker's current FCF Margin % of 5.71% is 12% below median its 10-year median of 6.52. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 11.82. Based on the distribution chart, Bruker ranks #393 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Bruker has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bruker's FCF Margin % compare to MASI and BIO?
According to the Medical Devices & Instruments industry distribution chart, Bruker ranks #393 out of 815 companies for FCF Margin %. This puts Bruker in the upper half of its industry. Historically, Bruker's own FCF Margin % has ranged from 0.40 to 11.82 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bruker and its competitors. Bruker's current FCF Margin % is 5.71%, which is 12% below median its own 10-year median of 6.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bruker stock overvalued right now?
Based on GuruFocus' analysis, Bruker (FRA:BKD) is currently considered Fairly Valued. The stock's GF Value™ is €53.30, compared to a current price of €52.66 — trading 1.2% below its estimated fair value. The current FCF Margin % is 5.71%, which is 12% below median its 10-year median of 6.52. Bruker's overall GF Score™ is 85/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bruker (FRA:BKD), the current FCF Margin % is 5.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bruker (FRA:BKD) Overvalued in 2026?
Based on GuruFocus' analysis, Bruker stock appears to be undervalued.
The current stock price of €52.66 is trading 1.2% below its estimated GF Value™ of €53.30.
GuruFocus considers Bruker to be Fairly Valued.
Key valuation signals for FRA:BKD:
FCF Margin %: 5.71% (12% below median its 10-year median of 6.52)
GF Value™: €53.30 vs. price of €52.66 (1.2% below fair value)
No single metric tells the full story. See the FRA:BKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
85GF Score
Get the complete analysis for FRA:BKD
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:BKD has been successfully added to your 
